ATHIRA PHARMA INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Athira Pharma, Inc. - ATHA
NEW ORLEANS, May 13, 2022
NEW ORLEANS, May 13, 2022 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into Athira Pharma, Inc. (NasdaqGS: ATHA).
On June 17, 2021, the Company disclosed that the Board of Directors had placed President and Chief Executive Officer Leen Kawas "on temporary leave pending a review of actions stemming from doctoral research [Kawas] conducted while at Washington State University," and that the Company's COO had "assumed day-to-day leadership responsibilities for the Company, effective immediately." That same day, STAT News reported that the investigation of Kawas related to allegations that she altered images in four separate research papers as the lead author while she was a graduate student.
The Company was subsequently sued in a securities class action lawsuit for failing to disclose material information, violating federal securities laws, which remains ongoing.
KSF's investigation is focusing on whether Athira's officers and/or directors breached their fiduciary duties to the Company's shareholders or otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or have been a long-term holder of Athira shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (email@example.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-atha/ to learn more.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.
To learn more about KSF, you may visit www.ksfcounsel.com.
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
1100 Poydras St., Suite 3200
New Orleans, LA 70163
View original content to download multimedia:https://www.prnewswire.com/news-releases/athira-pharma-investigation-continued-by-former-louisiana-attorney-general--kahn-swick--foti-llc-continues-to-investigate-the-officers-and-directors-of-athira-pharma-inc---atha-301547215.html
SOURCE Kahn Swick & Foti, LLC
PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
- CSE Bulletin: AMENDED - Consolidation - Northern Lights Resources Corp. (NLR)
- CSE Bulletin: Reinstatement - TraceSafe Inc. (TSF)
- Firan Technology Group Corporation Confirms Resignation of Director
- Redfin Reports Historic Housing Shortage Shows Signs of Letting Up as Sales Decline
- Timbercreek Financial Declares May 2022 Dividend
- Partners Value Investments Inc. Announces Q1 2022 Interim Results